RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 11 analysts with an average price target of $24.63. This is a potential upside of $21.58 (707.54%) from yesterday's end of day stock price of $3.05.

Rocket Pharmaceuticals's activity chart (see below) currently has 68 price targets and 106 ratings on display. The stock rating distribution of RCKT is 88.68% BUY and 11.32% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.54% with an average time for these price targets to be met of 150.5 days.

Highest price target for RCKT is $42, Lowest price target is $2, average price target is $28.33.

Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 03-Jun-2025. First documented stock forecast 27-Nov-2018.

Currently out of the existing stock ratings of RCKT, 47 are a BUY (88.68%), 6 are a HOLD (11.32%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$8.04 (271.62%)

$34

1 months 11 days ago
(03-Jun-2025)

0/9 (0%)

$8.04 (271.62%)

Buy

$8

$5.04 (170.27%)

$44

1 months 16 days ago
(28-May-2025)

1/10 (10%)

$5.52 (222.58%)

374

Buy

$17

$14.04 (474.32%)

$46

1 months 16 days ago
(28-May-2025)

3/13 (23.08%)

$14.52 (585.48%)

140

Buy

$44

1 months 16 days ago
(28-May-2025)

3/7 (42.86%)

$37.01 (529.47%)

227

Buy

$19

$16.04 (541.89%)

$51

1 months 16 days ago
(28-May-2025)

1/7 (14.29%)

$16.52 (666.13%)

145

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 150.5 days on average for the stock forecasts to be realized with a an average price target met ratio 19.54

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 8 price targets and 3 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Joshua Schimmer with highest potential upside - $56.4

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Richard Law with lowest potential downside - -$0.96

Rocket Pharmaceuticals in the News

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - RCKT

SAN DIEGO, July 08, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), have until Monday, August 11, 2025 to seek appointment as lead plaintiff of the Rocket...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. SO WHAT: If you...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?